Community protocols on TRT describe: CJC-1295 (no DAC): 100 mcg subcutaneous, 2-3x daily (pre-bed dose described as most important) CJC-1295 (with DAC): 2 mg subcutaneous, 1-2x per week Starting after the TRT protocol is stable (8+ weeks) Monitoring IGF-1 at the 4-week and 12-week marks For reconstitution and detailed protocols, see our CJC-1295 dosing guide and CJC-1295 DAC dosing guide
While glutathione supports health through well-established mechanisms, it is not a cure-all, and responsible providers communicate realistic expectations
Sterile water lacks a preservative, so bacteria can grow in the vial after the first puncture
One is by preventing the virus
Efficacy and safety of LY3298176 (tirzepatide), a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes (Phase 2 trial)
But maintaining solid B12 status ensures that one easily correctable biological variable isn't quietly undermining your mental health